Security
HCA Healthcare, Inc. · HCA
HCANYSECommon stockCurrentCIK 860730Updated Nov 7, 2026
HCA price & chart
Loading TradingView…
NYSE:HCA on TradingView ↗About the company
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies,
In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA ↗
Recent filings
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Other Events
Items 1.01, 2.03, 8.01, 9.01
FWP - filed by HCA Healthcare, Inc. regarding HCA Healthcare, Inc.
Other Events
Items 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure · Other Events
Items 2.02, 7.01, 8.01, 9.01
Show 5 more recent filings
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Other Events
Items 2.03, 8.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure · Other Events
Items 2.02, 7.01, 8.01, 9.01
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 59,747,000,000Source | 59,459,000,000Source | 54,589,000,000Source | 59,536,000,000Source | 57,379,000,000Source | 61,450,000,000Source | 59,798,000,000Source | 56,962,000,000Source | 60,720,000,000Source | 59,513,000,000Source | 56,211,000,000Source | 52,438,000,000Source |
| Property, Plant and Equipment, NetUSD | 30,568,000,000Source | 29,047,000,000Source | 27,117,000,000Source | 30,123,000,000Source | 28,639,000,000Source | 31,472,000,000Source | 29,738,000,000Source | 28,096,000,000Source | 31,141,000,000Source | 29,414,000,000Source | 27,715,000,000Source | 25,575,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 997,000,000Source | 2,888,000,000Source | 891,000,000Source | 939,000,000Source | 831,000,000Source | 940,000,000Source | 1,060,000,000Source | 1,284,000,000Source | 1,040,000,000Source | 1,933,000,000Source | 935,000,000Source | 908,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 10,428,000,000Source | 9,915,000,000Source | 9,182,000,000Source | 10,459,000,000Source | 10,239,000,000Source | 11,324,000,000Source | 11,088,000,000Source | 10,044,000,000Source | 10,867,000,000Source | 10,751,000,000Source | 9,958,000,000Source | 8,891,000,000Source |
| Inventory, NetUSD | 1,734,000,000Source | 1,776,000,000Source | 2,030,000,000Source | 1,792,000,000Source | 1,800,000,000Source | 1,681,000,000Source | 1,794,000,000Source | 1,903,000,000Source | 1,652,000,000Source | 1,738,000,000Source | 2,021,000,000Source | 2,068,000,000Source |
| Assets, CurrentUSD | 15,285,000,000Source | 16,662,000,000Source | 14,294,000,000Source | 15,563,000,000Source | 15,173,000,000Source | 16,052,000,000Source | 16,258,000,000Source | 15,282,000,000Source | 15,783,000,000Source | 16,414,000,000Source | 14,927,000,000Source | 13,643,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,115,000,000Source | 2,201,000,000Source | 2,079,000,000Source | 2,156,000,000Source | 2,179,000,000Source | 2,094,000,000Source | 2,132,000,000Source | 2,211,000,000Source | 2,130,000,000Source | 2,131,000,000Source | 2,207,000,000Source | 2,065,000,000Source |
| Other Assets, NoncurrentUSD | 277,000,000Source | 309,000,000Source | 200,000,000Source | 236,000,000Source | 240,000,000Source | 326,000,000Source | 226,000,000Source | 199,000,000Source | 255,000,000Source | 230,000,000Source | 184,000,000Source | 298,000,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Retained Earnings (Accumulated Deficit)USD | -5,020,000,000Source | -1,807,000,000Source | -1,989,000,000Source | -4,087,000,000Source | -1,170,000,000Source | -5,978,000,000Source | -3,164,000,000Source | -1,185,000,000Source | -5,724,000,000Source | -2,115,000,000Source | -1,352,000,000Source | -2,280,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -317,000,000Source | -378,000,000Source | -491,000,000Source | -309,000,000Source | -433,000,000Source | -327,000,000Source | -357,000,000Source | -433,000,000Source | -305,000,000Source | -387,000,000Source | -425,000,000Source | -490,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | -5,335,000,000Source | -2,182,000,000Source | -2,477,000,000Source | -4,394,000,000Source | -1,600,000,000Source | -6,303,000,000Source | -3,519,000,000Source | -1,615,000,000Source | -6,027,000,000Source | -2,499,000,000Source | -1,774,000,000Source | -2,767,000,000Source |
| Liabilities and EquityUSD | 59,747,000,000Source | 59,459,000,000Source | 54,589,000,000Source | 59,536,000,000Source | 57,379,000,000Source | 61,450,000,000Source | 59,798,000,000Source | 56,962,000,000Source | 60,720,000,000Source | 59,513,000,000Source | 56,211,000,000Source | 52,438,000,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 17,896,000,000Source | 14,900,000,000Source | 12,407,000,000Source | 15,939,000,000Source | 14,301,000,000Source | 19,258,000,000Source | 13,631,000,000Source | 13,141,000,000Source | 16,350,000,000Source | 15,177,000,000Source | 12,655,000,000Source | 9,902,000,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 352,000,000Source | 343,000,000Source | 363,000,000Source | 364,000,000Source |
| Accounts Payable, CurrentUSD | 4,552,000,000Source | 4,235,000,000Source | 4,139,000,000Source | 4,250,000,000Source | 4,029,000,000Source | 4,806,000,000Source | 4,488,000,000Source | 4,735,000,000Source | 4,659,000,000Source | 4,276,000,000Source | 4,233,000,000Source | 4,239,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,838,000,000Source | 1,924,000,000Source | 1,776,000,000Source | 1,881,000,000Source | 1,894,000,000Source | 1,822,000,000Source | 1,860,000,000Source | 1,912,000,000Source | 1,853,000,000Source | 1,863,000,000Source | 1,903,000,000Source | 1,752,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 3,176,000,000Source | 2,968,000,000Source | 2,834,000,000Source | 3,156,000,000Source | 2,939,000,000Source | 3,325,000,000Source | 3,081,000,000Source | 2,885,000,000Source | 3,256,000,000Source | 3,054,000,000Source | 2,834,000,000Source | 2,694,000,000Source |
| Additional Financial Items | ||||||||||||
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | -12,000,000Source | -14,000,000Source | -34,000,000Source | -14,000,000Source | -24,000,000Source | -12,000,000Source | -17,000,000Source | -23,000,000Source | -11,000,000Source | -21,000,000Source | -22,000,000Source | -30,000,000Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | -13,000,000Source | -65,000,000Source | -86,000,000Source | -13,000,000Source | -64,000,000Source | 5,000,000Source | -13,000,000Source | -64,000,000Source | 5,000,000Source | -13,000,000Source | -64,000,000Source | -87,000,000Source |
| Long-term Debt, Excluding Current Maturities | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | — | 4,682,000,000Source | 2,553,000,000Source | — | 4,574,000,000Source | — | 3,519,000,000Source | 3,028,000,000Source | — | 4,698,000,000Source | 2,424,000,000Source | 370,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 38,401,000,000Source | 38,283,000,000Source | 36,793,000,000Source | 39,379,000,000Source | 36,306,000,000Source | 39,491,000,000Source | 41,057,000,000Source | 37,163,000,000Source | 41,603,000,000Source | 38,333,000,000Source | 37,169,000,000Source | 37,714,000,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 1,903,000,000Source | 1,482,000,000Source | 1,891,000,000Source | 1,687,000,000Source | 1,857,000,000Source | 1,825,000,000Source | 7,782,000,000Source | 6,657,000,000Source | 6,091,000,000Source | 6,834,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 889,000,000Source | 842,000,000Source | 863,000,000Source | 819,000,000Source | 930,000,000Source | 860,000,000Source | 3,523,000,000Source | 3,312,000,000Source | 3,077,000,000Source | 2,969,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 86,000,000Source | 98,000,000Source | 401,000,000Source | 360,000,000Source | 262,000,000Source | 341,000,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 463,000,000Source | 327,000,000Source | 94,000,000Source | 799,000,000Source | 935,000,000Source | 797,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 2,014,000,000Source | 1,651,000,000Source | 12,636,000,000Source | 10,514,000,000Source | 9,431,000,000Source | 8,522,000,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -1,282,000,000Source | -1,032,000,000Source | -4,988,000,000Source | -4,933,000,000Source | -5,317,000,000Source | -3,389,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | 4,000,000Source | 3,000,000Source | -12,000,000Source | 5,000,000Source | 19,000,000Source | 21,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 1,119,000,000Source | 991,000,000Source | 4,944,000,000Source | 4,875,000,000Source | 4,744,000,000Source | 4,395,000,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 1,571,000,000Source | 2,506,000,000Source | 10,067,000,000Source | 6,042,000,000Source | 3,811,000,000Source | 7,000,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -830,000,000Source | -1,495,000,000Source | -8,550,000,000Source | -4,582,000,000Source | -4,094,000,000Source | -5,656,000,000Source |
| Dividends paid | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -262,000,000Source | -90,000,000Source | -185,000,000Source | -277,000,000Source | -246,000,000Source | -212,000,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 58,000,000Source | 3,895,000,000Source | 7,389,000,000Source | 2,410,000,000Source | 909,000,000Source | 2,830,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -100,000,000Source | -873,000,000Source | -893,000,000Source | 998,000,000Source | 27,000,000Source | -543,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 997,000,000Source | 2,888,000,000Source | 939,000,000Source | 831,000,000Source | 940,000,000Source | 1,060,000,000Source | 1,040,000,000Source | 1,933,000,000Source | 935,000,000Source | 908,000,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 569,000,000Source | 539,000,000Source | 2,207,000,000Source | 1,938,000,000Source | 1,892,000,000Source | 1,662,000,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | -5,000,000Source | 10,000,000Source | 1,740,000,000Source | 1,844,000,000Source | 1,386,000,000Source | 1,175,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -2,000,000Source | 3,000,000Source | 9,000,000Source | -1,000,000Source | 7,000,000Source | -20,000,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | 44,000,000Source | 35,000,000Source | 35,000,000Source | 29,000,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 11,000,000Source | 11,000,000Source | 44,000,000Source | 35,000,000Source | 35,000,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 12,000,000Source | 16,000,000Source | 20,000,000Source | 44,000,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 3,508,000,000Source | 3,294,000,000Source | 3,052,000,000Source | 2,941,000,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | -2,000,000Source | -4,000,000Source | -3,000,000Source | 12,000,000Source | -1,000,000Source | 1,000,000Source | 37,000,000Source | 14,000,000Source | -5,000,000Source | 1,301,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | -78,000,000Source |
| General and Administrative ExpenseUSD | — | — | 139,000,000Source | 111,000,000Source | 130,000,000Source | 100,000,000Source | 133,000,000Source | 126,000,000Source | 548,000,000Source | 421,000,000Source | 315,000,000Source | 378,000,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 16,000,000Source | 15,000,000Source | 19,000,000Source | 0Source | 9,000,000Source | 18,000,000Source | 78,000,000Source | 23,000,000Source | 22,000,000Source | 45,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 515,000,000Source | 424,000,000Source | 524,000,000Source | 550,000,000Source | 430,000,000Source | 502,000,000Source | 2,050,000,000Source | 1,866,000,000Source | 1,615,000,000Source | 1,746,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 1,643,000,000Source | 1,270,000,000Source | 1,653,000,000Source | 1,461,000,000Source | 1,620,000,000Source | 1,610,000,000Source | 6,784,000,000Source | 5,760,000,000Source | 5,242,000,000Source | 5,643,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 260,000,000Source | 212,000,000Source | 238,000,000Source | 226,000,000Source | 237,000,000Source | 215,000,000Source | 998,000,000Source | 897,000,000Source | 849,000,000Source | 1,191,000,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 484,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 0Source | 5,233,000,000Source | 8,474,000,000Source | 7,495,000,000Source | 3,224,000,000Source | 5,997,000,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 19,161,000,000Source | 17,487,000,000Source | 18,605,000,000Source | 17,492,000,000Source | 19,109,000,000Source | 18,321,000,000Source | 75,600,000,000Source | 70,603,000,000Source | 64,968,000,000Source | 60,233,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 2,418,000,000Source | 1,906,000,000Source | 2,415,000,000Source | 2,237,000,000Source | 2,287,000,000Source | 2,327,000,000Source | 9,832,000,000Source | 8,523,000,000Source | 7,706,000,000Source | 8,580,000,000Source |
| Income Tax Expense (Benefit)USD | — | — | 515,000,000Source | 424,000,000Source | 524,000,000Source | 550,000,000Source | 430,000,000Source | 502,000,000Source | 2,050,000,000Source | 1,866,000,000Source | 1,615,000,000Source | 1,746,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 260,000,000Source | 212,000,000Source | 238,000,000Source | 226,000,000Source | 237,000,000Source | 215,000,000Source | 998,000,000Source | 897,000,000Source | 849,000,000Source | 1,191,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 1,643,000,000Source | 1,270,000,000Source | 1,653,000,000Source | 1,461,000,000Source | 1,620,000,000Source | 1,610,000,000Source | 6,784,000,000Source | 5,760,000,000Source | 5,242,000,000Source | 5,643,000,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 7.05Source | 4.94Source | 6.91Source | 5.6Source | 7.25Source | 6.52Source | 28.7Source | 22.27Source | 19.25Source | 19.43Source |
| Earnings Per Share, DilutedUSD per share | — | — | 6.96Source | 4.88Source | 6.83Source | 5.53Source | 7.15Source | 6.45Source | 28.33Source | 22Source | 18.97Source | 19.15Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 232,891,000Source | 256,763,000Source | 239,173,000Source | 261,156,000Source | 223,588,000Source | 246,936,000Source | 236,413,000Source | 258,603,000Source | 272,404,000Source | 290,348,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 236,181,000Source | 259,917,000Source | 241,911,000Source | 264,071,000Source | 226,652,000Source | 249,440,000Source | 239,495,000Source | 261,806,000Source | 276,412,000Source | 294,666,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 12,000,000Source | 16,000,000Source | 20,000,000Source | 44,000,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | 0.72Source | 0.66Source | 0.72Source | 0.66Source | 0.78Source | 0.72Source | 2.88Source | 2.64Source | 2.4Source | 2.24Source |
| Costs and ExpensesUSD | — | — | 16,743,000,000Source | 15,581,000,000Source | 16,190,000,000Source | 15,255,000,000Source | 16,822,000,000Source | 15,994,000,000Source | 65,768,000,000Source | 62,080,000,000Source | 57,262,000,000Source | 51,653,000,000Source |
| General and Administrative ExpenseUSD | — | — | 139,000,000Source | 111,000,000Source | 130,000,000Source | 100,000,000Source | 133,000,000Source | 126,000,000Source | 548,000,000Source | 421,000,000Source | 315,000,000Source | 378,000,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 16,000,000Source | 15,000,000Source | 19,000,000Source | 0Source | 9,000,000Source | 18,000,000Source | 78,000,000Source | 23,000,000Source | 22,000,000Source | 45,000,000Source |
| Interest ExpenseUSD | — | — | 561,000,000Source | 515,000,000Source | 568,000,000Source | 506,000,000Source | 584,000,000Source | 547,000,000Source | 2,248,000,000Source | 2,061,000,000Source | 1,938,000,000Source | 1,741,000,000Source |
| Labor and Related ExpenseUSD | — | — | 8,364,000,000Source | 7,861,000,000Source | 8,138,000,000Source | 7,685,000,000Source | 8,283,000,000Source | 7,997,000,000Source | 32,859,000,000Source | 31,170,000,000Source | 29,487,000,000Source | 27,685,000,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 484,000,000Source |
| Other Cost and Expense, OperatingUSD | — | — | 4,161,000,000Source | 3,717,000,000Source | 3,793,000,000Source | 3,623,000,000Source | 4,180,000,000Source | 3,845,000,000Source | 15,886,000,000Source | 14,819,000,000Source | 12,875,000,000Source | 11,155,000,000Source |
Offerings
Registration 333-295336
Registration 333-295336-01
Filing attachments
hca-ex4_2.htm · 8-K · 2026-11-05
Exhibit 4.2 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.200% SENIOR NOTES DUE 2028 SUPPLEMENTAL INDENTURE NO. 57 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) 7.10 (a)(2) …
Read attachment ↗hca-ex4_3.htm · 8-K · 2026-11-05
Exhibit 4.3 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent FLOATING RATE SENIOR NOTES DUE 2028 SUPPLEMENTAL INDENTURE NO. 58 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) 7.10 (a)…
Read attachment ↗hca-ex4_4.htm · 8-K · 2026-11-05
Exhibit 4.4 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.350% SENIOR NOTES DUE 2029 SUPPLEMENTAL INDENTURE NO. 59 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) …
Read attachment ↗hca-ex4_5.htm · 8-K · 2026-11-05
Exhibit 4.5 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.500% SENIOR NOTES DUE 2031 SUPPLEMENTAL INDENTURE NO. 60 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) …
Read attachment ↗hca-ex4_6.htm · 8-K · 2026-11-05
Exhibit 4.6 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.750% SENIOR NOTES DUE 2033 SUPPLEMENTAL INDENTURE NO. 61 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) …
Read attachment ↗hca-ex4_7.htm · 8-K · 2026-11-05
Exhibit 4.7 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 6.000% SENIOR NOTES DUE 2036 SUPPLEMENTAL INDENTURE NO. 62 Dated as of November 5, 2026 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310 (a)(1) 7.10 (a)(2) …
Read attachment ↗